MX2009013116A - Derivados de prolinamida-tetrazol como antagonistas del receptor nk3. - Google Patents
Derivados de prolinamida-tetrazol como antagonistas del receptor nk3.Info
- Publication number
- MX2009013116A MX2009013116A MX2009013116A MX2009013116A MX2009013116A MX 2009013116 A MX2009013116 A MX 2009013116A MX 2009013116 A MX2009013116 A MX 2009013116A MX 2009013116 A MX2009013116 A MX 2009013116A MX 2009013116 A MX2009013116 A MX 2009013116A
- Authority
- MX
- Mexico
- Prior art keywords
- sup
- receptor antagonists
- halogen
- prolinamide
- hydrogen
- Prior art date
Links
- 102000002003 Neurokinin-3 Receptors Human genes 0.000 title abstract 2
- 108010040716 Neurokinin-3 Receptors Proteins 0.000 title abstract 2
- 239000002464 receptor antagonist Substances 0.000 title abstract 2
- 229940044551 receptor antagonist Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a un compuesto de fórmula (I): en donde R1 es cicloalquilo o es fenilo no sustituido o sustituido por uno o dos átomos de halógeno; R2 es hidrógeno o halógeno; R3 es hidrógeno, CN, alcoxi inferior, alquilo inferior o halógeno; n es 0, i ó 2; o a una sal de adición ácida farmacéuticamente adecuada de la misma. Se ha encontrado que los presentes compuestos son antagonistas del receptor NK-3 de alta potencia para el tratamiento de la depresión, dolor, psicosis, Parkinson, esquizofrenia, ansiedad y trastorno de déficit de atención e hiperactividad (ADHD).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07109783 | 2007-06-07 | ||
| PCT/EP2008/056587 WO2008148688A1 (en) | 2007-06-07 | 2008-05-29 | Prolinamide-tetrazole derivatives as nk3 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009013116A true MX2009013116A (es) | 2010-01-15 |
Family
ID=39768738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009013116A MX2009013116A (es) | 2007-06-07 | 2008-05-29 | Derivados de prolinamida-tetrazol como antagonistas del receptor nk3. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7501422B2 (es) |
| EP (1) | EP2155729B1 (es) |
| JP (1) | JP2010529068A (es) |
| KR (1) | KR101163294B1 (es) |
| CN (1) | CN101679385A (es) |
| AT (1) | ATE498622T1 (es) |
| AU (1) | AU2008258664B2 (es) |
| BR (1) | BRPI0812253A2 (es) |
| CA (1) | CA2690292A1 (es) |
| DE (1) | DE602008005014D1 (es) |
| ES (1) | ES2359598T3 (es) |
| IL (1) | IL202282A0 (es) |
| MX (1) | MX2009013116A (es) |
| WO (1) | WO2008148688A1 (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023042914A1 (en) * | 2021-09-17 | 2023-03-23 | Otsuka Pharmaceutical Co., Ltd. | Pyrrolidine compounds as histone deacetylase inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040034019A1 (en) | 2002-08-08 | 2004-02-19 | Ronald Tomlinson | Piperazine and piperidine derivatives |
-
2008
- 2008-05-29 KR KR1020107000225A patent/KR101163294B1/ko not_active IP Right Cessation
- 2008-05-29 BR BRPI0812253-9A2A patent/BRPI0812253A2/pt not_active IP Right Cessation
- 2008-05-29 WO PCT/EP2008/056587 patent/WO2008148688A1/en active Application Filing
- 2008-05-29 AT AT08760179T patent/ATE498622T1/de active
- 2008-05-29 EP EP08760179A patent/EP2155729B1/en not_active Not-in-force
- 2008-05-29 DE DE602008005014T patent/DE602008005014D1/de active Active
- 2008-05-29 MX MX2009013116A patent/MX2009013116A/es active IP Right Grant
- 2008-05-29 ES ES08760179T patent/ES2359598T3/es active Active
- 2008-05-29 JP JP2010510746A patent/JP2010529068A/ja not_active Ceased
- 2008-05-29 CN CN200880018987A patent/CN101679385A/zh active Pending
- 2008-05-29 AU AU2008258664A patent/AU2008258664B2/en not_active Ceased
- 2008-05-29 CA CA2690292A patent/CA2690292A1/en not_active Abandoned
- 2008-05-30 US US12/129,720 patent/US7501422B2/en not_active Expired - Fee Related
-
2009
- 2009-11-23 IL IL202282A patent/IL202282A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE498622T1 (de) | 2011-03-15 |
| US20080306089A1 (en) | 2008-12-11 |
| CN101679385A (zh) | 2010-03-24 |
| WO2008148688A1 (en) | 2008-12-11 |
| CA2690292A1 (en) | 2008-12-11 |
| KR101163294B1 (ko) | 2012-07-05 |
| EP2155729A1 (en) | 2010-02-24 |
| AU2008258664B2 (en) | 2012-07-05 |
| KR20100020026A (ko) | 2010-02-19 |
| IL202282A0 (en) | 2010-06-16 |
| US7501422B2 (en) | 2009-03-10 |
| BRPI0812253A2 (pt) | 2014-12-23 |
| JP2010529068A (ja) | 2010-08-26 |
| ES2359598T3 (es) | 2011-05-25 |
| AU2008258664A8 (en) | 2010-01-14 |
| AU2008258664A1 (en) | 2008-12-11 |
| DE602008005014D1 (de) | 2011-03-31 |
| EP2155729B1 (en) | 2011-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL202236A0 (en) | Prolinamide derivatives as nk3 antagonists | |
| MX2009008465A (es) | Nuevas 2-aminooxazolinas como ligandos de taar1. | |
| MX2009013591A (es) | Proceso para la preparacion de pirazoles. | |
| MX2010001774A (es) | Pirrolidin aril-eteres como antagonistas de receptores de nk3. | |
| CY1116778T1 (el) | Παραγωγα πυραζολιου | |
| MY176030A (en) | Substituted benzamide derivatives | |
| MY163164A (en) | Ethynyl derivatives as positive allosteric modulators of the mglur5 | |
| MX360667B (es) | Derivados de etinilo como moduladores alostericos del receptor de glutamato metabotropico del subtipo 5 (mglur5). | |
| MX2015014353A (es) | Derivados de 2-fenil- o 2-hetaril-imidazol[1,2-a]piridina. | |
| MX2012001799A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinona 3 (nk3). | |
| MX354815B (es) | Derivados heterociclicos como receptores asociados con las aminas traza (taars). | |
| ZA201002139B (en) | New compounds as adenosine a1 receptor antagonists | |
| MX2011008850A (es) | Derivados de piperidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
| MX2009005920A (es) | Nuevos 2-imidazoles como ligandos para receptores asociados con trazas de amina. | |
| MX361761B (es) | Derivados de triazol carboxamida. | |
| BR112012014576A2 (pt) | derivados de pirrolidina como antagonistas do receptor nk-3 | |
| PE20141168A1 (es) | Derivados de pirazolidin-3-ona | |
| MX2013007411A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
| MX2011008178A (es) | Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
| MX2009013116A (es) | Derivados de prolinamida-tetrazol como antagonistas del receptor nk3. | |
| MX2009006972A (es) | Derivados de espiropiperidina como antagonistas de neuroquinina 3. | |
| MX2011007506A (es) | Derivados de piperidina como antagonistas del receptor de neuroquinina 3 (nk3). | |
| MX2010002585A (es) | Derivados de piperidina como antagonistas del receptor nk3. | |
| MX2009013186A (es) | Derivados de piperazina y [1,4]diazepan como antagonistas de neurocinina. | |
| NZ582095A (en) | Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |